Documents
Application Sponsors
NDA 019617 | PHARMACIA AND UPJOHN | |
Marketing Status
Application Products
001 | GEL;ENDOCERVICAL | 0.5MG/3GM | 1 | PREPIDIL | DINOPROSTONE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 1992-12-09 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 1999-08-13 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 2001-06-07 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 2002-04-26 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2010-02-12 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 16 | AP | 2013-09-10 | STANDARD |
LABELING; Labeling | SUPPL | 17 | AP | 2017-07-05 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 18 | AP | 2015-02-03 | STANDARD |
Submissions Property Types
SUPPL | 3 | Null | 0 |
SUPPL | 4 | Null | 0 |
SUPPL | 10 | Null | 6 |
SUPPL | 16 | Null | 0 |
SUPPL | 17 | Null | 15 |
SUPPL | 18 | Null | 0 |
CDER Filings
PFIZER
cder:Array
(
[0] => Array
(
[ApplNo] => 19617
[companyName] => PFIZER
[docInserts] => ["",""]
[products] => [{"drugName":"PREPIDIL","activeIngredients":"DINOPROSTONE","strength":"0.5MG\/3GM","dosageForm":"GEL;ENDOCERVICAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"07\/05\/2017","submission":"SUPPL-17","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/019617s017lbl.pdf\"}]","notes":""},{"actionDate":"02\/12\/2010","submission":"SUPPL-10","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/019617s010lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"PREPIDIL","submission":"DINOPROSTONE","actionType":"0.5MG\/3GM","submissionClassification":"GEL;ENDOCERVICAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2017-07-05
)
)